Complete report ,300. DataPack (test volumes, sales forecasts, supplier shares) ,500.
This report presents detailed analyses of the AIDS diagnostics market in the UK. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot,
HTLV-I/II and other confirmatory tests performed in the following market segments:
- Commercial/Private Laboratories
- Blood Banks
- Public Health Laboratories
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
The report is based on a combination of primary and secondary information sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 251 pages and 7 tables
Table of Contents
for UK HIV/AIDS Diagnostics Market: Emerging Opportunities and Growth Strategies [Report Updated: 08-07-2016]
Table of Content - click REQUEST A SAMPLE BUTTON
List Of Tables
in UK HIV/AIDS Diagnostics Market: Emerging Opportunities and Growth Strategies [Report Updated: 08-07-2016]
- Beckman Coulter/Danaher
- Becton Dickinson
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- ID Biomedical/GSK
- Ortho-Clinical Diagnostics
- Takara Bio
- Thermo Fisher/Life Technology
Venture Planning Group (VPG)
59559 | VPID19643
Number of Pages
|Title||Date Published||Price from||More Details|
|Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class|
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
|01 Jun 2013 by FirstWord Pharma||USD $695||More Info|
|Effective sales and marketing strategies for drugs with companion diagnostics|
IntroductionTo fully exploit the commercial advantages of companion diagnostics, Pharma companies ne...
|01 May 2013 by FirstWord Pharma||USD $695||More Info|
|Biosimilars in Emerging Markets|
IntroductionWhat are the implications for regulators, biosimilar companies and branded manufacturers...
|01 Mar 2013 by FirstWord Pharma||USD $665||More Info|
|Driving Brand Value in Emerging Markets -- winning strategies and tactics|
IntroductionYour key to breaking new ground in emerging markets. It’s a case of old versus new: esta...
|01 Jan 2013 by FirstWord Pharma||USD $695||More Info|
|Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma|
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
|01 Jun 2012 by FirstWord Pharma||USD $995||More Info|
|Branded Generics in South East Asia: Current and Future Opportunities|
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
|01 Apr 2012 by FirstWord Pharma||USD $945||More Info|
|Market Access: Communicating Value Stories to Payers|
IntroductionThroughout the EU, reimbursement decisions are increasingly decentralised, making the pr...
|01 Apr 2012 by FirstWord Pharma||USD $695||More Info|
|Adapting to a New Environment: Emerging Segmentation Practice in the Pharmaceutical Industry|
Introduction“If you’re not talking segmentation, then you’re not talking marketing.” While German-...
|01 Feb 2012 by FirstWord Pharma||USD $595||More Info|
|Tiered Pricing Strategies in Emerging Markets|
IntroductionFor the pharmaceutical industry, emerging markets are dynamic, full of potential and off...
|01 Feb 2012 by FirstWord Pharma||USD $695||More Info|
|Gauging the Biosimilar Effect: will the market boom or bust?|
IntroductionIt was supposed to be the “epoch of biosimilars”, or drugs that copied existing biologic...
|01 Jan 2012 by FirstWord Pharma||USD $895||More Info|
This report is published by Venture Planning Group (VPG)
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.